Health TrialsbyHealthPanel

Salivary Gland Carcinoma

2

Review clinical trials related to Salivary Gland Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Abiraterone With Dalpiciclib in Salivary Gland Carcinoma

This study is a single center, non controlled, prospective phase II clinical trial to evaluate the efficacy and safety of abiraterone combined with dalpiciclib in recurrent/metastatic salivary gland carcinoma patients with AR positive and Her-2 negative. The participants would receive abiraterone combined with dalpiciclib until termination criteria are met.

Participants needed: 36
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityUpdated: Sep 11, 2026Locations: 1
Eligibility criteria

- Aged 18-75 years, male or female; [+14]

- Patients with prior exposure to anti-androgen therapy or CDK4/6 inhibitors. [+17]

Read more
Status: Recruiting

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Patients with salivary gland carcinoma were divided into groups according to HER2, NTRK, AR, TROP-2, etc. Patients in different groups were given precision targeted therapy or chemotherapy to evaluate the efficacy (ORR rate) and safety of precision therapy.

Participants needed: 39
Trial details
Phase: Phase 2Age: 18-100Biological sex: AllType: InterventionalSponsor: Peking Union Medical CollegeUpdated: Apr 2, 2026Locations: 2
Eligibility criteria

Patients with histopathologic diagnosis of salivary gland carcinoma [+4]

Known hypersensitivity or delayed anaphylaxis to any agents in this trial; [+7]

Read more